মাল্যাশিয়া - ইংরেজি - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

solution biologics sdn. bhd. - rad5-ncov -

মাল্যাশিয়া - ইংরেজি - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

solution biologics sdn. bhd. - rad5-ncov -

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

solco biomedical co., ltd. - zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z), titanium dioxide (unii: 15fix9v2jp) (titanium dioxide - unii:15fix9v2jp), octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w) - sunscreen take an appropriate amount of this product and spread evenly on the skin.

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

solco biomedical co., ltd. - dimethicone (unii: 92ru3n3y1o) (dimethicone - unii:92ru3n3y1o) - skin protectant - anti wrinkle, whitening take an appropriate amount of this product and spread evenly on the skin.

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

solco biomedical co., ltd. - aminocaproic acid (unii: u6f3787206) (aminocaproic acid - unii:u6f3787206) - toothpaste take a proper amount of toothpaste to the toothbrush and brush it

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

emergent biodefense operations lansing llc - brincidofovir (unii: 6794o900ax) (brincidofovir - unii:6794o900ax) - tembexa® is indicated for the treatment of human smallpox disease caused by variola virus in adult and pediatric patients, including neonates. tembexa is not indicated for the treatment of diseases other than human smallpox disease [see warnings and precautions (5.1, 5.2)] . the effectiveness of tembexa for the treatment of smallpox disease has not been determined in humans because adequate and well-controlled field trials have not been feasible, and inducing smallpox disease in humans to study the drug’s efficacy is not ethical [see clinical studies (14)] . tembexa efficacy may be reduced in immunocompromised patients based on studies in immune deficient animals. none. based on findings from animal reproduction studies, tembexa may cause fetal harm when administered to pregnant individuals. use an alternative therapy to treat smallpox during pregnancy, if feasible. there are no available data on the use of brincidofovir in pregnant individuals to evaluate for a drug-associated risk of major birth defects, m

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

emergent biodefense operations lansing llc - brincidofovir (unii: 6794o900ax) (brincidofovir - unii:6794o900ax) - tembexa® is indicated for the treatment of human smallpox disease caused by variola virus in adult and pediatric patients, including neonates. tembexa is not indicated for the treatment of diseases other than human smallpox disease [see warnings and precautions (5.1, 5.2)] . the effectiveness of tembexa for the treatment of smallpox disease has not been determined in humans because adequate and well-controlled field trials have not been feasible, and inducing smallpox disease in humans to study the drug’s efficacy is not ethical [see clinical studies (14)] . tembexa efficacy may be reduced in immunocompromised patients based on studies in immune deficient animals. none. risk summary based on findings from animal reproduction studies, tembexa may cause fetal harm when administered to pregnant individuals. use an alternative therapy to treat smallpox during pregnancy, if feasible. there are no available data on the use of brincidofovir in pregnant individuals to evaluate for a drug-associated risk of major bir

কানাডা - ইংরেজি - Health Canada

emergent biodefense operations lansing llc - anthrax antigen filtrate - suspension - 50mcg - anthrax antigen filtrate 50mcg - vaccines

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

emergent biodefense operations lansing, llc - bacillus anthracis strain v770-np1-r antigens (unii: 873oi62848) (bacillus anthracis strain v770-np1-r antigens - unii:873oi62848) - bacillus anthracis strain v770-np1-r antigens 100 ug in 1 ml - biothrax is a vaccine indicated for the active immunization for the prevention of disease caused by bacillus anthracis in persons 18 through 65 years of age. the efficacy of biothrax for post-exposure prophylaxis is based solely on studies in animal models of inhalational anthrax. do not administer biothrax to individuals with a history of anaphylactic or anaphylactic-like reaction following a previous dose of biothrax or any component of the vaccine, including aluminum, benzethonium chloride, and formaldehyde. [see description (11).] pregnancy category d. [see warnings and precautions (5.3)] healthcare practitioners are encouraged to register women who receive biothrax during pregnancy in emergent’s vaccination pregnancy registry by calling 1-619-553-9255. male fertility: a retrospective study was performed at an in-vitro fertilization clinic to evaluate whether biothrax may impact reproductive function in men. this study compared semen parameters, embryo quality, and pregnancy outcomes in 254 male cli

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

rimmel inc. - octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51) - octinoxate 300 mg in 4 g